Jadidi, Ali
Rezaei Ashtiani, Alireza
Khanmohamadi Hezaveh, Ali
Aghaepour, Seyed Mohamad
Article History
Received: 10 July 2022
Accepted: 30 November 2022
First Online: 31 December 2022
Declarations
:
: This study is authorized by the Arak University of Medical Sciences Ethics Committee, with the ethics code IR.ARAKMU.REC.1396.63. The study is registered at the National Center for Clinical Trial Registration, the identifier IRCT2017070134806N1. All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by ethics comettee of Arak Univerity of Medical Sciences. Informed consent was obtained from all subjects. They were informed that their involvement in the study was entirely voluntary, that they may withdraw from the study at any moment, and that their continuous collaboration would not affect their treatment. On the other hand, the surveys were anonymous, and the participants in the research were guaranteed that the collected data would be released without their names or addresses.
: N/A.
: There is no conflict of interests in this study.